6.2.3. post-dilatation/direct vision internal urethrotomy strategies. several strategies developed evaluated prevent wound contraction, improve stricture-free rate time stricture recurrence dilatation dviu. noteworthy strategies tend stabilise stricture rather keep patient stricture-free reported outcomes understood respect. 6.2.3.1. intermittent self-dilatation 6.2.3.1.1. results sr identified six randomised quasi-randomised trials comparing intermittent self-dilatation (isd) isd follow-up eight 24 months . stricture recurrence reduced men performing isd (85/197, 43%) vs. (128/207, 62%) (rr: 0.70; 95% ci: 0.48-1.00; p=0.05). significant heterogeneity, quality included studies low, led authors conclude uncertainty estimate . review found significant difference adverse events isd isd (rr: 0.60; 95% ci: 0.11-3.26; p=0.56) . one trial containing 48 patients found significant difference six vs. twelve months duration isd (rr: 0.67; 95% ci: 0.12-3.64) another trial (n=59) found significant difference using low-friction hydrophylic vs. polyvinyl chloride catheter (rr: 0.32; 95% ci: 0.07-1.40) . studies published sr 2014. chhabra et al., reported patients complying isd dilatation lower need re-intervention not, 12.3% vs. 20.5% respectively (p=0.2) . mean follow-up 25 months, greenwell et al., found need subsequent intervention 13/31 (42%) men performing isd vs. 47/95 (49%) (p=0.46). number reoperations patients need subsequent intervention lower group performing isd vs. (2.6 vs. 3.4). major complications reported groups . 6.2.3.1.2. complications potential benefit isd stabilising stricture must balanced drawbacks. commonly reported complications urethral bleeding (7.1%) uti/epididymitis (4.7-18.1%) . multicentric prospective study (n=85) reported respectively 35% 26% patients moderate severe difficulties catheterisation respectively 32% 17% patients suffered moderate severe pain performing isd. serious impact qol rated moderate poor 32% 55% patients, respectively . younger age identified predictor poor qol, qol impaired proximal stricture location (posterior bulbar) . study 286 patients (mainly > 60 years old) performing isd, 20% experienced problems isd 33% least one infection annually. mean follow-up 58 months 67% still continued isd . khan et al., reported eight “drop-outs” 30 (26.7%) men randomised isd . eight “drop-outs”, two unable perform isd one stopped pain. mentioned above, repetitive dilatation (including isd) increases stricture complexity delays time urethroplasty . 6.2.3.1.3. intermittent self-dilatation combined intra-urethral corticosteroids delay wound contraction stricture site, intra-urethral corticosteroids (as catheter lubricant) used improve results isd. 2014, sr identified three prospective rcts comparing isd local steroid (triamcinolone) ointment vs. isd without local steroid ointment . three studies included total 67 68 patients randomised local steroid, not, follow-up ranging twelve 36 months. fifteen (22.4%) recurrences steroid group 25 (36.7%) control group (or: 0.51; 95% ci: 0.24-1.10; p=0.09) . time recurrence longer steroid group vs. control group (weighted mean difference = 0.29; 95% ci: 0.08-1.00; p=0.05). difference adverse events groups . since 2014, two additional rcts published. ergun et al., evaluated patients dviu primary short (< 2 cm), bulbar (82%) posterior (18%) strictures randomised isd (n=30) isd + triamcinolone ointment (n=30) six weeks. stricture recurrence rate 24 months significantly different isd isd + triamcinolone (respectively 33.3 30%) . hand, regmi et al., found lower stricture recurrence rate (22% vs. 46%, p=0.04) patients performing isd + triamcinolone (n=27) vs. isd alone (n=28) . study, median time recurrence 7.4 ± 4.5 months vs. 11.9 ± 3 months respectively isd alone isd + triamcinolone (p=0.16). studies reported complications related ointment triamcinolone . small (n=28) cohort ls-related strictures, intra-urethral steroid regimen successful (no need subsequent escalation therapy) 25 (89%) patients mean follow-up 25 months . regimen consisted applying clobetasol cream 0.05% lubricant calibration device (10-16 fr catheter dilator) twice day minimum two months. patients continued instillation steroids calibration device, high “success” rate must viewed caution considered stabilisation stricture rather cure. eventually, twelve (42.8%) patients could reduce interval instillation/dilatation three (10.7%) could finally stop treatment . summary evidencelestricture recurrence reduced men performing intermittent self-dilatation (isd) versus not.1aintra-urethral corticosteroids addition isd delays time recurrence.1a recommendationsstrength ratingperform intermittent self-dilatation (isd) stabilise stricture dilatation/direct vision internal urethrotomy urethroplasty viable option.weakuse intra-urethral corticosteroids addition isd stabilise urethral stricture.weak 6.2.3.2. intralesional injections rationale adjuvant intralesional injections reduce fibroblast proliferation excessive urethral scaring . 6.2.3.2.1. steroids 2014 sr identified five studies comparing intra-urethral submucosal steroid injection vs. intra-urethral submucosal steroid injection dviu, two rcts . meta-analysis two rcts 57 58 patients in, respectively, steroid control group showed statistical difference recurrence rate (or: 0.53; 95% ci: 0.25-1.13; p=0.10). time recurrence significantly longer steroid group (weighted mean difference = 4.43; 95% ci: 2.77–6.09, p < 0.00001). significant differences regarding adverse events (infection, bleeding, extravasation) groups (weighted mean difference = 1.59; 95% ci: 0.71–3.58, p=0.26). 6.2.3.2.2. mitomycin c 2021 sr meta-analysis different adjuncts minimally invasive treatment urethral stricture men, mitomycin c (mmc) associated lowest rate urethral stricture recurrence (intralesional injection: 0.23, 95% ci 0.11-0.48; p<0.001; intraluminal injection: 0.11, 95% ci 0.02-0.61; p=0.01) . another sr meta-analysis 2021 xu et al., efficacy mmc combined direct vision internal urethrotomy, revealed effect mmc significant short (< 2cm), anterior urethral strictures, longer (>12 months) follow-up group . absence well-conducted adequately powered rcts along lack standardisation (dose, technique, volume, etc.) current literature, careful clinical review prospective data collection part clinical trial advised. 6.2.3.2.3. platelet rich plasma rezaei et al., conducted rct comparing dviu + platelet rich plasma (prp) (n=44) vs. dviu + saline (n=43) primary, bulbar strictures < 1.5 cm length . two-year stricture-free rate 78% vs. 56% dviu without prp, respectively (p=0.034). complications frequent significantly different groups (dviu + prp: 70%; dviu + saline: 79%). complications (urethral bleeding, haematuria, urethral pain, pelvic pain, urinary leakage genitoperineal swelling) classified grade 1 according clavien-dindo system. validation treatment needed general clinical implementation. summary evidenceleintralesional injections direct vision internal urethrotomy (dviu) might improve stricture-freerates short-term compared dviu alone. experience limited use drugs off-label. significant uncertainty exists drug, dose, volume technique.1a recommendationstrength ratinguse intralesional injections confines clinical trial.weak 6.2.3.3. urethral stents urethral stents designed aim oppose wound contraction dilatation dviu . stent insertion short procedure (< 60 minutes) done local spinal anaesthesia “one day” surgery . urethral stents classified permanent temporary (removable, six twelve months). 6.2.3.3.1. results permanent stainless-steel mesh stents longer commercially available. rct comparing dilatation/dviu vs. dilatation/dviu followed temporary stent insertion bulbar strictures reported significantly longer stricture-free survival time favour dilation/dviu followed stent (median 292 vs. 84 days; p < 0.001) . 20.6% patients treated stent developed recurrent stricture within one year vs. 82.8% control group. results corroborated prospective series wong et al., found median stricture-free survival two months dviu alone vs. 23 months dviu followed temporary (three months) stent bulbar strictures . failure need re-intervention frequent (30-53%) usually stricture recurrence, stent encrustation, stent migration urethral hyperplasia. complications include recurrent uti, recurrent haematuria genito-perineal pain (table 6.5). although stents mainly used treat bulbar strictures, used posterior stenoses well. stents used posterior urethra high risk (82-100%) causing ui pronounced patients previous irradiation and/or strictures extending membranous bulbar urethra . bulbar urethra, risk ui higher stent placement adjacent external sphincter . use stents penile urethra anecdotal. jung et al., reported stent failure 4/7 (57%) patients penile stricture mean follow-up eight months. patients failed, patient distal pan-penile strictures rendered stricture-free . series, stricture recurrence stenting penile urethra significantly higher compared bulbar urethra . although direct comparison available, temporary stents tend fewer less severe complications compared permanent stents (table 6.7). 6.2.3.4. drug-coated balloon dilatation drug (paclitaxel)-coated balloon dilatation (dcbd) standard dilatation dviu aims reduce scar formation based antimitotic action. robust-3 trial prospectively randomized patients predominantly bulbar strictures (< 3cm length) least two prior failed endoscopic treatments dcbd (n=79) standard dilatation/dviu (n=48) . anatomic patency (assessed cystoscopy) six months 75% dcbd versus 27% standard dilatation/dviu (p<0.001). estimated one year-retreatment free survival 83% versus 22% respectively dcbd standard dilatation/dviu (p<0.001). serious adverse events related dcbd although patients undergoing dcbd higher rate hematuria dysuria compared controls (11.4% versus 2.1%). paclitaxel detected semen six months treatment urges contraception partner child-bearing potential. used, careful clinical review prospective data collection ideally part post marketing registry clinical trial advised. summary evidenceledrug (paclitaxel)-coated balloon dilatation associated higher anatomic patency rates (at sixmonths) lower risk retreatment (at one year) compared standard dilatation/dviu patients short (< 3 cm), bulbar strictures underwent least two prior failed endoscopic treatments.1b recommendationstrength ratingoffer drug (paclitaxel)-coated balloon dilatation short (< 3 cm) bulbar stricture recurring least two prior endoscopic treatments, patients urethroplasty option.weak 6.2.3.4.1. treatment stent failure case stent failure, subsequent urethroplasty (usually stent removal) possible, urethroplasty likely complex would performed initially [251-253]. due fact stainless-steel wires fully embedded urethral wall, time urethral spongiosum severely damaged. horiguchi et al., found history urethral stenting independent significant predictor increased stricture complexity (or: 13.7; 95% ci: 1.7-318.3; p=0.01) need complex urethroplasty (or: 6.9; 95% ci: 1.1-64.5; p=0.04) . majority (62%) patients study permanent stent tend difficult remove epithelialised, usually within six months . type urethroplasty required depends length stricture quality local tissues . majority cases, possible preserve urethral plate perform one-stage substitution urethroplasty . patency rates different types urethroplasty vary greatly 16.7-100% [251-254] variation probably reflects variation complexity stricture, rather superiority one technique urethroplasty another (for information see supplementary table s6.2). due limitations, use stents avoided subsequent urethroplasty considered . urethral stents first-line treatment urethral strictures considered co-morbid patients recurrent stricture dviu/dilatation unable complex urethroplasty refuse urethroplasty . summary evidencelepermanent urethral stents high complications failure rate make subsequent urethroplasty challenging fail.3stents higher failure rate penile urethra.3temporary stents dviu (direct vision internal urethrotomy) /dilatation bulbar urethra prolong time next recurrence compared dviu/dilatation alone.1b recommendationsstrength ratingdo use permanent urethral stents.strongdo use urethral stents penile strictures.stronguse temporary stent recurrent bulbar strictures direct vision internal urethrotomy prolong time next recurrence urethroplasty viable option.weak